Atypical chronic lung disease patterns in neonates

Pediatrics

Volumn 103, Issue 4 I, 1999, Pages 759-765

  Charafeddine, Lama ^a   D'Angio, Carl T ^a   Phelps, Dale L ^a,b  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b Golisano Childrens Hospital at Strong   (United States)

Author keywords

Bronchopulmonary dysplasia; Chronic pulmonary insufficiency of prematurity; Wilson Mikity

Indexed keywords

CORTICOSTEROID; DEXAMETHASONE; LUNG SURFACTANT;

ARTICLE; ASSISTED VENTILATION; BIRTH WEIGHT; CHRONIC LUNG DISEASE; FEMALE; HUMAN; INCIDENCE; INFANT; LUNG DYSPLASIA; MAJOR CLINICAL STUDY; MALE; NEWBORN; OXYGEN THERAPY; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY DISTRESS SYNDROME; RETROSPECTIVE STUDY;

BRONCHOPULMONARY DYSPLASIA; CHRONIC DISEASE; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; INFANT, VERY LOW BIRTH WEIGHT; INTENSIVE CARE UNITS, NEONATAL; LUNG DISEASES; MALE; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 0033059093     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.103.4.759     Document Type: Article

References (23)

1. Parker R, Lindstrom D, Cotton R. Improved survival accounts for most, but not all, of the increase in bronchopulmonary dysplasia. Pediatrics. 1992;90:663-668
2. Schwartz R, Luby A, Scanlon J, Kellogg R. Effect of surfactant on morbidity, mortality and resource use in newborn infants weighing 500 to 1500 g. N Engl J Med. 1994;330:1476-1480
3. Wung J, Koons A, Driscoll J, James L. Changing incidence of bronchopulmonary dysplasia. J Pediatr. 1979;95:845-847
4. Rojas AM, Gonzales A, Bancalari E, Claure N, Poole C, Silva-Neto G. Changing trends in the epidemiology and pathogenesis of neonatal chronic lung disease. J Pediatr. 1995;126:605-610
5. Le Guennec J, Rufai M, Papageorgiou A. Spectrum of oxygen dependency in surviving infants weighing 600 to 1000 grams: decreased incidence of severe chronic lung disease. Am J Permatol. 1993;10:292-296
6. Hudak B, Egan E. Impact of lung surfactant therapy on chronic lung diseases in premature infants. Clin Perinatol. 1992;19:591-602
7. Northway WJ, Rosan R, Porter D. Pulmonary disease following respirator therapy of hyaline membrane disease. Bronchopulmonary dysplasia. N Engl J Med. 1967;276:357-368
8. Wilson M, Mikity V. A new form of respiratory disease in premature infants. AMA J Dis Child. 1960;99:119/489-129/499
9. Krauss A, Klain D, Auld P. Chronic pulmonary insufficiency of prematurity. Pediatrics. 1975;55:55-58
10. Bancalari E, Abdenour G, Feller R, Gannon J. Bronchopulmonary dysplasia: clinical presentation. J Pediatr. 1979;95:819-823
11. Shennan A, Dunn M, Ohlsson A, Lennox K, Hoskins E. Abnormal pulmonary outcomes in premature infants: prediction from oxygen requirement in the neonatal period. Pediatrics, 1988;82:527-532
12. Charafeddine L, D'Angio C, Phelps D. Characteristics of infants with three patterns of neonatal chronic lung disease. Pediatr Res. 1996;39:200. Abstract
13. Cummings J, D'Eugenio D, Gross S. A controlled trial of dexamethasone in preterm infants at high risk for bronchopulmonary dysplasia. N Engl J Med. 1989;320:1505-1510
14. Ariagno R, Fulroth R, Baldwin R, Glotzbach S. Incidence of bronchopulmonary dysplasia, growth failure, and pulmonary dysfunction assessed by clinical scoring. J Perinatol. 1991;XI:311-314
15. Van Marter L, Leviton A, Kuban K, Pagano M, Allred E. Maternal glucocorticoid therapy and reduced risk of bronchopulmonary dysplasia. Pediatrics. 1990;86:331-336
16. Avery M, Tooley W, Keller J, et al. Is chronic lung disease in low birth weight infants preventable. Pediatrics. 1987;79:26-30
17. Saigal S, Rosenbaum P, Stoskopf B, Sinclair J. Outcome in infants 501 to 1000 gm birth weight delivered to residents of the McMaster Health Region. J Pediatr. 1984;105:969-976
18. Edwards D, Dyer W, Northway W Jr. Twelve years' experience with bronchopulmonary dysplasia. Pediatrics. 1977;59:839-846
19. Horbar J, McAuliffe T, Adler S, et al. Variability in 28-day outcomes for very low birth weight infants: an analysis of 11 neonatal intensive care units. Pediatrics. 1988;82:554-559
20. Van Lierde S, Smith J, Devlieger H, Eggermont E. Outcome of respiratory distress syndrome at 28 days: a prospective longitudinal study. Eur Respir J. 1992;5:1243-1248
21. Crowley P, Chalmers J, Kreise M. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. Br J Obstet Gynaecol. 1990;97:11-25
22. Jobe A, Mitchell B, Gunkel J. Beneficial effects of the combined use of prenatal corticosteroids and postnatal surfactant on preterm infants. Am J Obstet Gynaecol. 1993;168:508-513
23. Doyle L, Kitchen W, Ford G, Rickards A, Lissenden J, Ryan M. Effects of antenatal steroid therapy on mortality and morbidity in very low birth weight infants. J Pediatr. 1986;108:287-292